Nerve symptom decision aid for breast cancer patients
Part of Cancer, Skin clinical trials.
This study tests a decision aid tool that helps people with breast cancer and nerve-related side effects from chemotherapy (like numbness or tingling) make better choices about their treatment. If you're on your third round of taxane chemo and have these symptoms, this tool may help you talk with your doctor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer and are currently on your third round of taxane chemotherapy (a common type of chemo).
- You have numbness or tingling in your hands or feet (even mild) from your chemo treatment.
- You have a smartphone or tablet that can access an online survey while you're in the waiting room.
- Your medical oncologist agrees that you can join this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a diet program delivered online to help reduce nerve damage symptoms like numbness and tingling caused by chemotherapy. It is for cancer survivors who completed treatment and still have these symptoms.
This study looks at mild or no nerve damage in the hands and feet after breast cancer chemotherapy. Researchers want to understand this condition better and find ways to help.
This trial tests whether acupuncture and compression therapy can prevent nerve damage caused by taxane chemotherapy in early-stage breast cancer. It aims to reduce numbness, tingling, or pain in the hands and feet.
This study tests a smartphone app that uses game-like features to help you manage nerve-related side effects (like tingling or numbness) during chemotherapy. It aims to support you in handling these symptoms.
This study tests whether remote check-ins (via phone/app/website) can help manage chemotherapy-related nerve pain in the hands and feet. It enrolls adults who developed nerve symptoms after certain cancer medicines and need ongoing monitoring.
This study looks at chemotherapy-related nerve damage (often felt as numbness, tingling, or pain) and why it happens and should matter. You may be eligible if you had a normal nerve check before chemotherapy started, or if your nerve symptoms are stable after finishing treatment.
Hear when a new Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.